“A new mobile app launched globally by the Food and Drug Administration Thursday empowers health care providers to access and report fresh uses of existing medicines and medical devices for patients with difficult-to-treat infectious diseases through a one-stop internet-based repository.”
“’The CURE ID application focuses on drugs for infectious diseases lacking adequate treatments, including neglected tropical diseases, emerging infectious threats and infections caused by antimicrobial-resistant organisms,’ FDA’s Principal Deputy Commissioner Dr. Amy Abernethy said. ‘When health care professionals directly input their clinical cases into the app, CURE ID allows these real-world experiences to be organized and analyzed much faster, making it easier to spot promising new uses for existing drugs.’”
“According to the FDA, clinical professionals are permitted to prescribe legally marketed human drugs or medical devices for uncleared uses when they deem it medically appropriate for an individual patient. Created through a collaboration between the agency and the National Institute of Health’s National Center for Advancing Translational Sciences, the app harnesses crowdsourcing to leverage new medical observations around the outcomes that occur when certain drugs are used in new populations, doses and combinations or for new indications…” Read the full article here.
Source: FDA Launches App to Report Fresh Uses for Existing Drugs – By Brandi Vincent, December 6, 2019. Nextgov.
